L. Satriano

Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy

M. Avila, M. Martínez-Chantar, J. Marin, 2019, Hepatology.

Analysis of the composition and regulation of the SLX4 complex

L. Satriano, 2014 .

MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells.

B. Nielsen, L. Roberts, J. Koshiol, 2022, Journal of hepatology.

Metabolic rearrangements in primary liver cancers: cause and consequences

P. Rodrigues, J. Banales, J. Andersen, 2019, Nature Reviews Gastroenterology & Hepatology.

Therapeutic Potential of Pharmacoepigenetics in Cholangiocarcinoma

J. Andersen, C. O’Rourke, D. V. Oliveira, 2019, Pharmacoepigenetics.

PIAS2-mediated blockade of IFN-β signaling: a basis for sporadic Parkinson disease dementia

T. Gasser, M. Prinz, E. Tresse, 2021, Molecular Psychiatry.

A morphogenetic EphB/EphrinB code controls hepatopancreatic duct formation

D. Wilkinson, J. Andersen, E. Ober, 2019, Nature Communications.

Structure of wild type and mutant F508del CFTR: A small-angle X-ray scattering study of the protein-detergent complexes.

R. Ford, N. Pollock, O. Moran, 2016, Journal of structural biology.